Skip Navigation

What Europe has to offer biotechnology companies

Posted. 21.05.2012

Overview

Unravelling the tax, financial and regulatory framework.

National governments have done much to encourage innovation, often through a web of tax incentives for research. Yet, by and large, they have done too little to ensure that these ideas are translated into new businesses, new products, additional jobs and so, in time, a faster rate of economic growth.

What Europe has to offer biotechnology companies: Unraveling the tax, financial and regulatory framework is a joint report by Ernst & Young and EuropaBio. In it, we examine what European countries have to offer investors, entrepreneurs and researchers alike.

We look at everything from what to take into account when determining the best location for research and development to how best exploit intellectual property (IP) within Europe’s various jurisdictions.

Download full Report
Competing for Growth - Chapter 1

Competing for Growth - Chapter 1